| Alina S Popa, MD | |
|
4445 Magnolia Ave, Riverside, CA 92501-4135 | |
| (951) 788-3636 | |
| Not Available |
| Full Name | Alina S Popa |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 4445 Magnolia Ave, Riverside, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003893348 | NPI | - | NPPES |
| 156612100 | Medicaid | MN | |
| ENROLLED | Medicaid | MN | |
| P00646046 | Other | MN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 49589 (Minnesota) | Secondary |
| 207R00000X | Internal Medicine | 107794 (California) | Secondary |
| 208M00000X | Hospitalist | 107794 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Community Hospital | Riverside, CA | Hospital |
| Manatee Memorial Hospital | Bradenton, FL | Hospital |
| Lakewood Ranch Medical Center | Bradenton, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alertive Healthcare Medical Group Apc | 9335543974 | 20 |
News Archive
Men with prostate cancer benefit from treatment with the pioneering drug olaparib - the first cancer drug to target inherited mutations - according to the results of a major trial presented today (Tuesday).
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, causes lethal respiratory paralysis within several years of diagnosis. There are no effective treatments to slow or halt this devastating disease.
A protein implicated in many biological processes also may play a role in memory, according to a study led by the University of Southern California and the National Institute on Aging at the National Institutes of Health.The findings, published this week in the Journal of Neuroscience, agree with research by a different team published online by Nature on July 11. Both studies found that mice lacking the protein SIRT1 exhibited impaired memory and learning, suggesting SIRT1's importance to those functions.
For many couples IVF is the last hope they have of having a baby and with some IVF clinics committing such blunders as implanting the wrong embryos or fertilizing the egg with the wrong man's sperm, these hope can soon turn into a nightmare.
Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").
› Verified 2 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376646869 PECOS PAC ID: 3577476761 Enrollment ID: O20031112000695 |
News Archive
Men with prostate cancer benefit from treatment with the pioneering drug olaparib - the first cancer drug to target inherited mutations - according to the results of a major trial presented today (Tuesday).
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, causes lethal respiratory paralysis within several years of diagnosis. There are no effective treatments to slow or halt this devastating disease.
A protein implicated in many biological processes also may play a role in memory, according to a study led by the University of Southern California and the National Institute on Aging at the National Institutes of Health.The findings, published this week in the Journal of Neuroscience, agree with research by a different team published online by Nature on July 11. Both studies found that mice lacking the protein SIRT1 exhibited impaired memory and learning, suggesting SIRT1's importance to those functions.
For many couples IVF is the last hope they have of having a baby and with some IVF clinics committing such blunders as implanting the wrong embryos or fertilizing the egg with the wrong man's sperm, these hope can soon turn into a nightmare.
Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").
› Verified 2 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811255060 PECOS PAC ID: 8527223304 Enrollment ID: O20120628000360 |
News Archive
Men with prostate cancer benefit from treatment with the pioneering drug olaparib - the first cancer drug to target inherited mutations - according to the results of a major trial presented today (Tuesday).
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, causes lethal respiratory paralysis within several years of diagnosis. There are no effective treatments to slow or halt this devastating disease.
A protein implicated in many biological processes also may play a role in memory, according to a study led by the University of Southern California and the National Institute on Aging at the National Institutes of Health.The findings, published this week in the Journal of Neuroscience, agree with research by a different team published online by Nature on July 11. Both studies found that mice lacking the protein SIRT1 exhibited impaired memory and learning, suggesting SIRT1's importance to those functions.
For many couples IVF is the last hope they have of having a baby and with some IVF clinics committing such blunders as implanting the wrong embryos or fertilizing the egg with the wrong man's sperm, these hope can soon turn into a nightmare.
Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").
› Verified 2 days ago
| Entity Name | Alertive Healthcare Medical Group Apc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467024331 PECOS PAC ID: 9335543974 Enrollment ID: O20210804002898 |
News Archive
Men with prostate cancer benefit from treatment with the pioneering drug olaparib - the first cancer drug to target inherited mutations - according to the results of a major trial presented today (Tuesday).
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, causes lethal respiratory paralysis within several years of diagnosis. There are no effective treatments to slow or halt this devastating disease.
A protein implicated in many biological processes also may play a role in memory, according to a study led by the University of Southern California and the National Institute on Aging at the National Institutes of Health.The findings, published this week in the Journal of Neuroscience, agree with research by a different team published online by Nature on July 11. Both studies found that mice lacking the protein SIRT1 exhibited impaired memory and learning, suggesting SIRT1's importance to those functions.
For many couples IVF is the last hope they have of having a baby and with some IVF clinics committing such blunders as implanting the wrong embryos or fertilizing the egg with the wrong man's sperm, these hope can soon turn into a nightmare.
Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alina S Popa, MD 4445 Magnolia Ave, Riverside, CA 92501-4135 Ph: (951) 788-3636 | Alina S Popa, MD 4445 Magnolia Ave, Riverside, CA 92501-4135 Ph: (951) 788-3636 |
News Archive
Men with prostate cancer benefit from treatment with the pioneering drug olaparib - the first cancer drug to target inherited mutations - according to the results of a major trial presented today (Tuesday).
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, causes lethal respiratory paralysis within several years of diagnosis. There are no effective treatments to slow or halt this devastating disease.
A protein implicated in many biological processes also may play a role in memory, according to a study led by the University of Southern California and the National Institute on Aging at the National Institutes of Health.The findings, published this week in the Journal of Neuroscience, agree with research by a different team published online by Nature on July 11. Both studies found that mice lacking the protein SIRT1 exhibited impaired memory and learning, suggesting SIRT1's importance to those functions.
For many couples IVF is the last hope they have of having a baby and with some IVF clinics committing such blunders as implanting the wrong embryos or fertilizing the egg with the wrong man's sperm, these hope can soon turn into a nightmare.
Avicena Group, Inc. has announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent #7,285,573 for the use of the Company's proprietary drug candidates for the treatment of amyotrophic lateral sclerosis ("ALS" or "Lou Gehrig's Disease").
› Verified 2 days ago
Amanjot Rangi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 951-353-2000 | |
Adnan Misellati, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7117 Brockton Ave, Riverside, CA 92506 Phone: 951-782-3616 | |
Chibuzo Ugochi Eke, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 900 University Ave, 2608 School Of Medicine Education Building, Riverside, CA 92521 Phone: 951-827-7669 Fax: 951-827-7688 | |
Taraneh Sarlati, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10800 Magnolia Ave, Riverside, CA 92505 Phone: 951-353-3016 | |
Victor Fayad, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4445 Magnolia Ave, Riverside, CA 92501 Phone: 951-788-3000 | |
Dr. Rashid Altafi, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 6850 Brockton Ave Ste A, Riverside, CA 92506 Phone: 626-859-2249 | |
Calvin Purushottam Patel, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3865 Jackson St, Ste. 106-526, Riverside, CA 92503 Phone: 951-688-2211 |